All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 191 of 206 pages ‹ First < 189 190 191 192 193 > Last ›
HSL9576
McCormick EM.
How drug sampling has become involved in drug diversion
Pharmacy Times 1988 May;54:134-137
HSL9579
Mossinghoff GJ.
Opposition to therapeutic interchange.
Am J Hosp Pharm 1988 May;45:(5):1065
HSL3627
Anstice DW.
Diflunisal advertising [2nd of 2 replies]
Medical Journal of Australia 1988 Apr 18;148:418, 420
HSL3556
Krass M.
New code for drug makers tightens rules on drug samples, research.
CMAJ 1988 Apr 1;138:(7):646
HSL3626
Good promotional practice (GPP)
Health Action International 1988 Apr;
www.haiweb.org
HSL9573
Simonsen LL.
Top 200 drugs of 1987: new prescription volume increases 4.2% moving total Rxs up 1.4%
Pharmacy Times 1988 Apr;54:38-46
HSL9578
Illinois Supreme Court rules on third party liability for hospitals
American Journal of Hospital Pharmacy 1988 Apr;45:741-742
HSL9580
Fay JT.
Seeking self-reliance
Wholesale Drugs Magazine 1988 Apr-May;40:14
HSL20216
Baron J, Hershey JC.
Outcome bias in decision evaluation.
J Pers Soc Psychol 1988 Apr;54:(4):569-79
http://www.ncbi.nlm.nih.gov/pubmed/3367280
HSL3567
Miles S.
Searle's "Patient Promise".
N Engl J Med 1988 Mar 24;318:(12):790
HSL9568
Roberts K, Sharp JR.
Original packs-what do patients think?
Pharmaceutical Journal 1988 Mar 19;240:382-384
HSL2094
Taylor SE, Brown JD.
Illusion and well-being: a social psychological perspective on mental health.
Psychol Bull 1988 Mar;103:(2):193-210
http://content.apa.org/journals/bul/103/2/193
HSL9554
Top 50 generics of 1987
American Druggist 1988 Mar;197:83-84, 87
HSL9581
Segal R, Grines LL.
Prescribing authority for pharmacists as viewed by organized pharmacy, organized medicine, and the pharmaceutical industry.
Drug Intell Clin Pharm 1988 Mar;22:(3):241-6
HSL9583
Penna PM.
Marketing formulary drug products: pharmacy-industry cooperation
American Journal of Hospital Pharmacy 1988 Mar;45:518
HSL9585
Brandon W.
Let the manufacturer explain increases.
Am Pharm 1988 Mar;NS28:(3):6
HSL3539
Cohen EP.
Direct-to-the-public advertisement of prescription drugs.
N Engl J Med 1988 Feb 11;318:(6):373-6
HSL3553
[No authors listed] Related Articles, Links Guidelines on postmarketing surveillance.
Joint committee of ABPI, BMA, CSM, and RCGP.
Br Med J (Clin Res Ed) 1988 Feb 6;296:(6619):399-400
HSL3623
MaLAM letter follow up—Janssen
1988 Feb;
HSL3624
Re: the promotion of penicillin/streptomycin combination
1988 Feb;
HSL9571
Schwartz H.
Fee for service will never be outdated
Pharmaceutical Executive 1988 Feb;8:12, 14
HSL9572
Detels P.
Adding OTCs to ethicals: double markets or double trouble?
Pharmaceutical Executive 1988 Feb;8:43-44, 46
HSL3569
Murdoch JC.
An open assessment of tenoxicam in the treatment of acute gout in general practice.
N Z Med J 1988 Jan 27;101:(838):21
HSL3621
Wells F.
Management of clinical trials.
Lancet 1988 Jan 16;1:(8577):124
HSL3606
Rubin JN, Widerhorn J, Elkayam U.
Nitroglycerin tolerance.
N Engl J Med 1988 Jan 14;318:(2):120
HSL3619
Weary PE.
Free drug samples: Use and abuse.
Arch Dermatol 1988 Jan 12;4:(1):125-7
HSL1876
[No authors listed]
"A matter of influence": graduate medical education and commercial sponsorship.
N Engl J Med. 1988 Jan 7;318(1):52-4 1988 Jan 7;318:(1):52-4
HSL3547
[No authors listed] Related Articles, Links Improving medical education in therapeutics.
Health and Public Policy Committee, American College of Physicians.
Ann Intern Med 1988 Jan;108:(1):145-7
HSL3566
McLeod DC.
Pharmaceutical marketing--rewriting the textbook.
Drug Intell Clin Pharm 1988 Jan;22:(1):62
HSL3622
Re: the promotion of vitamins A & E
1988 Jan;
HSL9551
Harvey KJ.
Influence of advertising over prescribing
Australian Journal of Hospital Pharmacy 1988 Jan;18:25-27
HSL1877
Bowman MA, Pearle DL.
Changes in drug prescribing patterns related to commercial company funding of continuing medical education.
J Contin Educ Health Prof 1988;8:(1):13-20
HSL3528
Breaches of Code of Pharmaceutical Marketing Practice
Lancet 1988;1:1179
HSL3529
International drug marketing code
Lancet 1988;1:988
HSL3530
International medical advertising
Lancet 1988;1:350
HSL3531
New marketing promotion guidelines for drug firms
Ontario Medical Review 1988;55:(3):57-58
HSL3532
Post-marketing surveillance by drug manufacturers
Lancet 1988;2:977
HSL3533
Promoting health or promoting drugs? A HAI presentation on rational drug use
Health Action International 1988;
www.haiweb.org
HSL3534
An unscrupulous advertisement
Lancet 1988;1:1098
HSL3535
Baldini R.
Nitroglycerin tolerance
New England Journal of Medicine 1988;318:120
HSL3536
Bone S, Wild R.
A glimpse before publication
Lancet 1988;1:1054
HSL3537
Boyle JA.
Searle’s “patient promise”
New England Journal of Medicine 1988;318:790
HSL3538
Cohen EP.
Advertising of prescription drugs
New England Journal of Medicine 1988;319:314-315
HSL3540
Collier J, Herxheimer A.
Medicines Act passes crucial test
Lancet 1988;1:1349
HSL3541
Ferguson A.
Commercial pharmaceutical medicine and medicalization: a case study from El Salvador
1988;
HSL3542
Frishman W.
Pharmaceutical company-sponsored symposia and medical ethics
American Journal of Medicine 1988;85:597
HSL3543
Goldfinger S.
“A matter of influence”: graduate medical education and commercial sponsorship
New England Journal of Medicine 1988;318:53
HSL3544
Harvey K.
The impact of the WHO ethical criteria for medicinal drug promotion: a study by Health Action International (HAI)
1988;4
www.haiweb.org
HSL3545
Harvey K.
The influence of advertising over prescribing
Australian Journal of Hospital Pharmacy 1988;18:(3):25-28
HSL3546
Hawkins JW, Aber CS.
The content of advertisements in medical journals: distorting the image of women.
Women Health 1988;14:(2):43-59
HSL3548
Heilman SR.
“A matter of influence”: graduate medical education and commercial sponsorship
New England Journal of Medicine 1988;318:53
HSL3549
Hemminki E.
Commercial information on drugs: confusing the physician?
Journal of Drug Issues 1988;18:245-257
HSL3550
Holloway WJ.
“A matter of influence”: graduate medical education and commercial sponsorship
New England Journal of Medicine 1988;318:New England Journal of Medicin
HSL3551
Hopley PJ, Rich AJ.
Pharmaceutical company representatives - an activity analysis
Pharmaceutical Journal 1988;241:R21-22
HSL3552
Hurwitz MA, Caves RE.
Persuasion or information? Promotion and the shares of brand name and generic pharmaceuticals
Journal of Law and Economics 1988;31:299-320
HSL3557
Kunin CM.
“A matter of influence”: graduate medical education and commercial sponsorship
New England Journal of Medicine 1988;318:53
HSL3559
Lefkowitz D.
Rap sheet on reps: the doctor will see you now
Pharmaceutical Executive 1988;8:(6):
HSL3561
Lexchin J.
Introducing a new drug: an objection
Canadian Family Physician 1988;34:1009-1010
HSL3562
Lexchin J.
Pharmaceutical promotion in New Zealand.
Community Health Stud 1988;12:(3):264-72
HSL3563
Marsh AA.
Junk mail
Canadian Medical Association Journal 1988;138:791
HSL3564
Masson A, Rubin PH.
Advertising of prescription drugs
New England Journal of Medicine 1988;319:314
HSL3565
McGregor M.
Pharmaceutical “generosity” and the medical profession
Annals of the Royal College of Physicians and Surgeons of Canada 1988;21:289
HSL3568
Mossinghoff GJ.
Costs of drug advertising
New England Journal of Medicine 1988;319:798
HSL3572
Osiobe SA.
Physicians’ and pharmacists’ drug information sources in Nigeria
Drug Information Journal 1988;22:553-563
HSL3573
Palmer WH, Ross DL.
Introducing a new drug: a response
Canadian Family Physician 1988;34:1010
HSL3574
Pearse WH.
Advertising of prescription drugs
New England Journal of Medicine 1988;319:314
HSL3575
Peay MY, Peay ER.
The role of commercial sources in the adoption of a new drug.
Soc Sci Med 1988;26:(12):1183-9
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=2905075&query_hl=47
HSL3576
Pitt L, Nel D.
Pharmaceutical promotion tools—their relative importance
European Journal of Marketing 1988;22:7-14
HSL3577
Pleil AM, Pathak DS.
Commercial drug compendium information: a First World/Third World comparison.
Int J Health Serv 1988;18:(4):587-602
HSL3602
Relman AS.
“A matter of influence”: graduate medical education and commercial sponsorship
New England Journal of Medicine 1988;318:53-54
HSL3603
Relman AS.
Minorities in the Journal’s advertisements
New England Journal of Medicine 1988;319:58
HSL3604
Roizen R.
Why I oppose drug company payment of physician/investigators on a per patient/subject basis
IRB: a review of human subjects research 1988;10:(1):9-10
HSL3605
Rosenblatt RA.
“A matter of influence”: graduate medical education and commercial sponsorship
New England Journal of Medicine 1988;318:52-53
HSL3607
Schiedermayer , McKinney WP.
The Feldene connection: drug dealing in the doctors’ parking lot?
New England Journal of Medicine 1988;319:1291-1292
HSL3609
Semple PF.
Disguised promotion of drugs
Lancet 1988;1:768
HSL3612
Sterky G, Tomson G, Sachs L, Henningsson B, Bergman U.
Medicines and society: a challenge in health development
1988;
HSL3614
Tan M.
Dying for drugs: pill power and politics in the Philippines
1988;
HSL3616
Tuthill JE.
“A matter of influence”: graduate medical education and commercial sponsorship
New England Journal of Medicine 1988;318:53
HSL3617
Verma S.
“A matter of influence”: graduate medical education and commercial sponsorship
New England Journal of Medicine 1988;318:52
HSL3625
Scott JE.
Ad performance insights
Medical Marketing & Media 1988;23:(2):32, 34, 36
HSL3628
Bell KD.
Diflunisal advertising [1st of 2 replies]
Medical Journal of Australia 1988;148:418
HSL3629
Mansfield PR.
Diflunisal advertising
Medical Journal of Australia 1988;148:418
HSL3646
Hardon A.
Towards rational drug-use in urban primary health care
Drug Monitor 1988;3:(10):111-119
HSL3661
Anderson A.
Imovane (zopiclone)
New Zealand Medical Journal 1988;102:647
HSL3662
Arya T.
Popularize trade names through proper advertisements only and not through scientific articles
Journal of the Association of Physicians of India 1988;37:733
HSL3663
Attanasio AE.
Medical technology in Italy
Lancet 1988;2:109
HSL3665
Bass M.
Biased Medifacts tape: comment
Canadian Family Physician 1988;35:2219
HSL9533
Stoker A, Jeffery R.
Pharmaceuticals and health policy: an Indian example.
Soc Sci Med 1988;27:(5):563-7
HSL9552
Legislation: pharmaceuticals and related products
International Digest of Health Legislation 1988;39:(4):886-896
HSL9584
Hammond CM.
Peoples's choice: Part 2: Cashing in on consumer research
Pharmaceutical Executive 1988;8:44, 46, 48
HSL15306
Denig P, Haaijer-Ruskamp FM, Zijsling DH.
How physicians choose drugs.
Soc Sci Med 1988;27:(12):1381-6
http://www.ncbi.nlm.nih.gov/pubmed/3238456
HSL15543
Pitt L, Nel D.
Pharmaceutical Promotion Tools--Their Relative Importance.
European Journal of Marketing 1988;22:(5):7-14
http://info.emeraldinsight.com/products/journals/journals.htm?PHPSESSID=l8l21ct3plsq3a52q73jef09v0&id=ejm
HSL19394
Hurwitz M, Caves R
Persuasion or information? promotion and the shares of brand name and generic pharmaceuticals
J Law Econ 1988;31:299–320
http://ideas.repec.org/a/ucp/jlawec/v31y1988i2p299-320.html
HSL20237
DePaulo PJ
Research on Deception in Marketing Communications: It's relevance to the study of nonverbal behaviour
Journal of Nonverbal Behaviour 1988;12:(4):253-273
http://www.springerlink.com/content/t0661536617g0h2k/
HSL2336
Soumerai SB, Avorn J, Gortmaker S, Hawley S.
Effect of government and commercial warnings on reducing prescription misuse: the case of propoxyphene.
Am J Public Health 1987 Dec;77:(12):1518-23
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=3674250&query_hl=59
HSL9586
AMA official OKs MD dispensing but rejects RPh prescribing
American Druggist 1987 Dec;197:28, 32, 36
HSL9590
Mossinghoff GJ.
How PMA companies have tightened their control of MD samples
Pharmacy Times 1987 Dec;53:55-57
HSL3432
Hampton JR, Julian DG.
Role of the pharmaceutical industry in major clinical trials.
Lancet 1987 Nov 28;2:(8570):1258-9
HSL3421
Crook D.
Drug promotion.
N Z Med J 1987 Nov 25;100:(836):725
HSL9592
Information for patients about medicines.
Lancet. 1987 Nov 7;2:(8567):1077-8
Page 191 of 206 pages ‹ First < 189 190 191 192 193 > Last ›
